CN Stock MarketDetailed Quotes
300639 Guangdong Hybribio Biotech
- 6.41
- -0.25-3.75%
Trading Dec 17 14:57 CST
4.14BMarket Cap-14.12P/E (TTM)
6.69High6.33Low130.06KlotVolume6.66Open6.66Pre Close84.04MTurnover2.05%Turnover Ratio29.54P/E (Static)646.50MShares9.3452wk High0.92P/B4.07BFloat Cap4.3252wk Low7.99Limit Up635.16MShs Float21.22Historical High5.33Limit Down5.41%Amplitude2.56Historical Low0.07Dividend TTM6.46Avg Price73.06KlotAsk1.01%Div YieldTTM100Lot Size55.22KlotBid
Guangdong Hybribio Biotech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -28.26%610.24M | -32.60%408.88M | -39.39%183.1M | -80.27%1.1B | -80.03%850.63M | -78.66%606.63M | -80.00%302.11M | 109.39%5.6B | 113.82%4.26B | 118.89%2.84B |
| Operating revenue | -28.26%610.24M | -32.60%408.88M | -39.39%183.1M | -80.27%1.1B | -80.03%850.63M | -78.66%606.63M | -80.00%302.11M | 109.39%5.6B | 113.82%4.26B | 118.89%2.84B |
| Other operating revenue | ---- | -48.28%7.36M | ---- | -62.03%29.75M | ---- | -48.23%14.23M | ---- | 196.44%78.35M | ---- | 425.96%27.49M |
| Total operating cost | -13.05%678.69M | -8.26%476.91M | -15.14%228.64M | -61.18%1.1B | -64.56%780.56M | -64.84%519.85M | -66.18%269.43M | 79.14%2.83B | 87.96%2.2B | 87.66%1.48B |
| Operating cost | -13.59%281.85M | -10.36%189.55M | -21.46%90.99M | -74.90%430.42M | -75.84%326.17M | -76.24%211.46M | -75.04%115.86M | 98.19%1.71B | 108.66%1.35B | 100.09%889.9M |
| Operating tax surcharges | 13.70%7.6M | -0.20%3.85M | -11.93%1.8M | -52.02%10.33M | -51.76%6.68M | -61.83%3.86M | -55.82%2.04M | 67.07%21.52M | 50.98%13.85M | 91.01%10.11M |
| Operating expense | 8.06%171M | 13.16%115.5M | -26.62%53.78M | -39.35%279.12M | -54.41%158.25M | -65.93%102.07M | -62.60%73.28M | 20.26%460.21M | 28.91%347.14M | 72.03%299.56M |
| Administration expense | -8.63%167.46M | -4.03%119.04M | -5.93%55.11M | -34.61%253.36M | -36.47%183.28M | -34.15%124.04M | -44.03%58.58M | 94.69%387.46M | 78.59%288.51M | 68.82%188.36M |
| Financial expense | -469.25%-14.11M | -56.93%3.13M | 114.74%2.67M | -309.39%-11.51M | -91.10%3.82M | -27.19%7.27M | -730.52%-18.08M | -173.81%-2.81M | 873.46%42.93M | 448.16%9.99M |
| -Interest expense (Financial expense) | -64.43%1.37M | -64.20%882.73K | -91.83%463.53K | -39.57%4.94M | -5.67%3.85M | -22.39%2.47M | 385.65%5.68M | 10.56%8.18M | -1.91%4.08M | 41.38%3.18M |
| -Interest Income (Financial expense) | -13.99%-17.95M | 23.03%-9.05M | -59.46%-2.58M | -121.99%-33.5M | -152.24%-15.74M | -265.94%-11.76M | 7.16%-1.62M | -280.50%-15.09M | -748.96%-6.24M | -288.61%-3.21M |
| Research and development | -36.59%64.9M | -35.58%45.84M | -35.63%24.3M | -44.87%136.32M | -35.85%102.36M | -11.76%71.15M | 28.73%37.75M | 114.48%247.28M | 99.14%159.56M | 60.24%80.63M |
| Credit Impairment Loss | -7,476.32%-382.09M | -946.06%-73.89M | -38.60%9.93M | 104.10%10.28M | 104.27%5.18M | 91.51%-7.06M | 131.09%16.17M | -385.23%-251.03M | -276.98%-121.45M | -169.40%-83.15M |
| Asset Impairment Loss | -192.40%-21.01M | -104.91%-802.26K | -97.28%81.17K | 97.22%-9.98M | 2,832.17%22.74M | 1,532.37%16.33M | 683.66%2.98M | -113,769.01%-359.24M | -1,214.43%-832.13K | -4,874.78%-1.14M |
| Other net revenue | -772.82%-388.38M | -265.71%-63.37M | -50.09%13.96M | 106.29%36.18M | 165.19%57.72M | 170.59%38.24M | 166.86%27.96M | -2,723.70%-575.47M | -680.88%-88.54M | -176.79%-54.18M |
| Fair value change income | 94.12%-513.72 | 238.10%7.45K | -1,204.98%-36.87K | -104.30%-1.83K | -126.76%-8.73K | -100.82%-5.39K | -106.01%-2.83K | -70.28%42.66K | --32.64K | --656.92K |
| Invest income | -18.20%8.81M | -36.95%7.3M | 2,032.87%1.39M | -34.56%13.94M | -42.47%10.77M | -29.26%11.57M | -102.80%-71.91K | 4.17%21.31M | 35.63%18.72M | 158.97%16.36M |
| -Including: Investment income associates | 70.01%-200.62K | 77.78%-157.26K | 47.99%-299.96K | 24.72%-843.13K | 0.31%-668.91K | -57.84%-707.74K | -82.49%-576.72K | -386.83%-1.12M | ---670.97K | ---448.38K |
| Asset deal income | -75.14%1.68M | -88.36%791.92K | 1,858.31%317.28K | 62.79%7.06M | -16.81%6.77M | -17.58%6.8M | -99.74%16.2K | 85.65%4.34M | 292.20%8.14M | 529.73%8.26M |
| Other revenue | -65.56%4.23M | -69.58%3.22M | -74.36%2.27M | 63.23%14.87M | 79.43%12.28M | 119.00%10.6M | 349.69%8.87M | 4.32%9.11M | 38.94%6.84M | 32.99%4.84M |
| Operating profit | -457.49%-456.83M | -205.09%-131.4M | -152.07%-31.58M | -98.06%42.6M | -93.51%127.79M | -90.45%125.03M | -90.98%60.64M | 104.25%2.19B | 143.34%1.97B | 166.68%1.31B |
| Add:Non operating Income | 106.04%1.02M | 383.36%831.18K | 898.49%674.05K | 122.38%587.65K | 131.63%495.61K | 91.63%171.96K | 13,844.27%67.51K | -89.99%264.25K | -91.17%213.97K | -69.60%89.73K |
| Less:Non operating expense | -34.00%4.66M | -42.82%2.33M | 49.08%2.59M | -90.28%6.37M | -75.71%7.05M | -82.22%4.08M | 31.41%1.74M | 240.83%65.57M | 1,715.66%29.04M | 4,612.17%22.95M |
| Total profit | -479.82%-460.46M | -209.73%-132.9M | -156.80%-33.5M | -98.27%36.82M | -93.75%121.23M | -90.59%121.12M | -91.21%58.97M | 101.28%2.13B | 139.53%1.94B | 162.12%1.29B |
| Less:Income tax cost | -1,411.28%-59.74M | -111.18%-3.55M | -145.01%-5.7M | -109.72%-31.7M | -98.61%4.56M | -85.52%31.76M | -89.38%12.67M | 89.30%326.06M | 160.33%328.03M | 172.73%219.3M |
| Net profit | -443.45%-400.72M | -244.76%-129.35M | -160.02%-27.79M | -96.20%68.51M | -92.76%116.67M | -91.63%89.36M | -91.61%46.31M | 103.61%1.8B | 135.70%1.61B | 160.04%1.07B |
| Net profit from continuing operation | -443.45%-400.72M | -244.76%-129.35M | -160.02%-27.79M | -96.20%68.51M | -92.76%116.67M | -91.63%89.36M | -91.61%46.31M | 103.61%1.8B | 135.70%1.61B | 160.04%1.07B |
| Less:Minority Profit | -150.41%-138.8M | -56.56%-52.42M | 29.44%-13.44M | -194.92%-71.96M | -145.14%-55.43M | -137.49%-33.48M | -136.63%-19.05M | 131.28%75.81M | 235.81%122.79M | 357.20%89.32M |
| Net profit of parent company owners | -252.19%-261.92M | -162.62%-76.93M | -121.96%-14.35M | -91.86%140.47M | -88.44%172.1M | -87.44%122.84M | -86.92%65.35M | 102.54%1.73B | 130.04%1.49B | 150.19%978.31M |
| Earning per share | ||||||||||
| Basic earning per share | -253.92%-0.4068 | -162.89%-0.1195 | -113.33%-0.02 | -90.46%0.25 | -88.36%0.2643 | -87.27%0.19 | -86.96%0.15 | 35.05%2.62 | 54.14%2.271 | 68.37%1.4929 |
| Diluted earning per share | -253.92%-0.4068 | -162.89%-0.1195 | -113.33%-0.02 | -90.46%0.25 | -88.36%0.2643 | -87.27%0.19 | -86.96%0.15 | 35.05%2.62 | 54.14%2.271 | 68.37%1.4929 |
| Other composite income | -132.85%-6.57M | -60.87%9.72M | 103.10%838.66K | -79.04%17.42M | -76.81%19.98M | -23.98%24.84M | -1,375.43%-27.06M | -11.93%83.1M | 13,833.07%86.17M | 1,913.51%32.68M |
| Other composite income of parent company owners | -132.85%-6.57M | -60.87%9.72M | 103.10%838.66K | -79.04%17.42M | -76.81%19.98M | -23.98%24.84M | -1,375.43%-27.06M | -11.93%83.1M | 13,833.07%86.17M | 1,913.51%32.68M |
| Total composite income | -398.03%-407.28M | -204.76%-119.63M | -240.04%-26.96M | -95.44%85.93M | -91.95%136.66M | -89.62%114.2M | -96.50%19.25M | 92.47%1.88B | 148.53%1.7B | 169.18%1.1B |
| Total composite income of parent company owners | -239.77%-268.49M | -145.51%-67.21M | -135.29%-13.52M | -91.27%157.89M | -87.80%192.09M | -85.39%147.68M | -92.31%38.3M | 91.13%1.81B | 143.59%1.57B | 159.75%1.01B |
| Total composite income of minority owners | -150.41%-138.8M | -56.56%-52.42M | 29.44%-13.44M | -194.92%-71.96M | -145.14%-55.43M | -137.49%-33.48M | -136.63%-19.05M | 131.28%75.81M | 235.81%122.79M | 357.20%89.32M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
